SNWV
SANUWAVE Health, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.25
−0.38%Oct 28, 2026, 22:05 UTC
Sanuwave Health, Inc. and SANUWAVE Health, Inc. amended their credit agreement with the lenders and JPMorgan Chase Bank, N.A., Toronto Branch, waiving a specified fixed-charge-coverage-ratio default and changing lender-consent requirements and permitted thresholds.
Sep 25, 2026, 20:48 UTC
SANUWAVE Health, Inc. received a Nasdaq notice dated September 23, 2026 that it no longer complies with the $35 million minimum market value of listed securities requirement under Nasdaq Listing Rule 5450(b)(2)(A), giving it until March 22, 2027 to regain compliance.
Aug 6, 2026, 21:00 UTC
Sanuwave reported Q2 FY2026 financial results with revenues of $9.7 million, down 3% from $10.1 million in Q2 2025, and gross margin of 76.2% versus 78.1% in Q2 2025.